ClinicalTrials.gg
Drug

Pitolisant clinical trials

Also written BF2.649 and wakix.

studies test it
31
open now
2
in phase 3
17
first study started
2007

How each study uses pitolisant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the pitolisant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Aug 2019 · WAKIX · NDA 211150 (FDA, Drugs@FDA)
European Union
31 Mar 2016 · Wakix · EMEA/H/C/002616 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pitolisant
24
Pitolisant (BF2.649)
3
BF2.649 (pitolisant)
2

Brand

wakix
2

Development codes

BF2.649
14
HBS-101
1

Studies by the year they started

30 studies that test it; most in 2011 (4)

Studies that test pitolisant, by start year
YearStudies
20071
20081
20093
20103
20114
20121
20131
20164
20171
20191
20201
20212
20223
20232
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
7
Phase 3
17
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 24

Bioprojet (20) · Harmony Biosciences Management, Inc. (5) · University of Oxford (1) · Citrine Medicine Limited (1) · University of Texas Southwestern Medical Center (1) · Boston Medical Center (1) · High Point Clinical Trials Center (1) · William Ondo, MD (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test pitolisant, phase 3 first.

Studies

Open first, then newest update. How each study uses pitolisant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test pitolisant →

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call pitolisant · ClinicalTrials.gg INT005032

  • MeSH (NLM) C516975pitolisantConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 4BC83L4PIYPITOLISANTConfirmed FDA, NLM, Wikidata
  • RxNorm 2197878Confirmed FDA, Wikidata
  • Wikidata Q426044pitolisantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166747PitolisantOne source FDA
  • DrugBank DB11642One source Wikidata

Also registered as pitolisant hydrochloride (UNII YV33CH63HI · RxNorm 2197879).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.